Open Orphan chief to underwrite part of £30m hVivo takeover

Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm

Open Orphan chief executive Cathal Friel: his underwriting will only kick in if the company fails to raise the cash from external investors